Maxim Group analyst Michael Okunewitch maintained a Buy rating on BioRestorative Therapies (BRTX – Research Report) yesterday and set a price target of $6.00. The company’s shares opened today at $3.24.
According to TipRanks, Okunewitch is an analyst with an average return of -25.9% and a 15.79% success rate. Okunewitch covers the Healthcare sector, focusing on stocks such as Mediwound, Citius Pharmaceuticals, and Gilead Sciences.
BioRestorative Therapies has an analyst consensus of Moderate Buy, with a price target consensus of $10.50.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $5.98 and a one-year low of $2.46. Currently, BioRestorative Therapies has an average volume of 594.6K.
Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of BRTX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Read More on BRTX:
- BRTX Blasts Up with New Patent
- BioRestorative receives notice of allowance by USPTO for ThermoStem program
- BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program
- BioRestorative announces notice of allowance by EPO for ThermoStem program
